SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page27282930Next Page
2026-08-21AEON3Ownership Filing for AEON Biopharma, Inc.MEDIUM
This filing details the ownership of AEON Biopharma, Inc. (AEON) by Timothy P. Lynch, who is a ten percent owner. The filing includes information on derivative holdings, specifically pre-funded warrants and regular warrants, all of which are exercisable for Class A Common Stock. The pre-funded warrants are exercisable ...
Nano CapBiotechnology
2026-08-21HEPA3Notification of Initial Beneficial Ownership - Hepion Pharmaceuticals, Inc.
This filing reports the initial beneficial ownership of James Gordon Liddy in Hepion Pharmaceuticals, Inc. (HEPA). Mr. Liddy, who is a director of the company, has reported no securities owned as of August 19, 2026. The filing is made in accordance with SEC regulations for reporting changes in beneficial ownership....
Biotechnology
2026-08-21AEON Biopharma, Inc.3Ownership Filing for AEON Biopharma, Inc.DuplicateMEDIUM
This filing details the ownership of AEON Biopharma, Inc. (AEON) by Timothy P. Lynch, who is a ten percent owner. The filing includes information on derivative holdings, specifically pre-funded warrants and regular warrants, all of which are exercisable for Class A Common Stock. The pre-funded warrants are exercisable ...
Nano CapBiotechnology
2026-08-21Hepion Pharmaceuticals, Inc.3Notification of Initial Beneficial Ownership - Hepion Pharmaceuticals, Inc.Duplicate
This filing reports the initial beneficial ownership of James Gordon Liddy in Hepion Pharmaceuticals, Inc. (HEPA). Mr. Liddy, who is a director of the company, has reported no securities owned as of August 19, 2026. The filing is made in accordance with SEC regulations for reporting changes in beneficial ownership....
Biotechnology
Previous Page27282930Next Page